I agree
I thought that the bulk of the short unwinding activities would have happened last week, but Shortman is showing that there has been an increased of short positions - go figure
But, as a LTSH, I now have no fear of these professional shorters.
In fact, there's 37m shares to be purchased at a future date
Shorters used to win against Mesoblast, as there was always an exit pathway, mainly via CR.
But, the game has shifted.
Mesoblast got access to plenty of cash/ funds; and are likely to get more in terms of partnership $$$
Also, the convincing ODAC approval recommendation of 9-1 has put to bed about Mesoblast not have achieved anything.
In a space of a few months, Mesoblast will be achieving plenty.
So, I'm mildly curious as to why they professional shorters have increased their position on MSB, whereby now their is a higher risk to them - there's plenty of other ASX stock for them to focus on - go figure
- Forums
- ASX - By Stock
- MSB
- MSB Trading 2020 - a new dawn
MSB Trading 2020 - a new dawn, page-1196
-
- There are more pages in this discussion • 11,875 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.18 |
Change
0.013(1.07%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $1.337M | 1.142M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 4669 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 62263 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 26523 | 1.180 |
11 | 87565 | 1.175 |
17 | 170954 | 1.170 |
9 | 62095 | 1.165 |
10 | 538552 | 1.160 |
Price($) | Vol. | No. |
---|---|---|
1.185 | 39425 | 6 |
1.190 | 87323 | 12 |
1.195 | 96155 | 14 |
1.200 | 121481 | 17 |
1.205 | 95665 | 6 |
Last trade - 11.05am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online